Successful treatment of cardiac involvement in dermatomyositis with rituximab

Joint Bone Spine

Volumn 75, Issue 3, 2008, Pages 334-337

  Touma, Zahi ^a   Arayssi, Thurayya ^a   Kibbi, Lina ^a   Masri, Abdel Fattah ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Cardiac disease; Dermatomyositis; Rituximab

Indexed keywords

ANTINUCLEAR ANTIBODY; CD20 ANTIGEN; CORTICOSTEROID DERIVATIVE; CREATINE KINASE; CREATINE KINASE MB; ETANERCEPT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; TROPONIN I; TROPONIN T;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; CD4+ T LYMPHOCYTE; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; HUMAN TISSUE; MUSCLE ATROPHY; MUSCLE NECROSIS; POLYARTHRITIS; PROTEIN BLOOD LEVEL; RAYNAUD PHENOMENON; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULITIS;

ADULT; ANTIBODIES, MONOCLONAL; DERMATOMYOSITIS; FEMALE; HEART DISEASES; HUMANS; IMMUNOLOGIC FACTORS;

EID: 42949138026     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.05.011     Document Type: Article

References (17)

1. Oddis C.V., and Medsger T.J. Inflammatory muscle disease: clinical features. In: Hochberg M.C. (Ed). Rheumatology. 3rd ed. (2003), Elsevier Saunders, Philadelphia 1537-1554
2. Wortmann R.L. Inflammatory diseases of muscle and other myopathies. In: Harris E.J., Budd R., Firestein G.S., Genovese M.C., Sergent J.S., Ruddy S., et al. (Eds). Kelley's textbook of rheumatology. 7th ed. (2005), Elsevier Saunders, Philadelphia 1309-1335
3. Lundberg I.E. Cardiac involvement in autoimmune myositis and mixed connective tissue disease. Lupus 14 (2005) 708-712
4. Allanore Y., Vignaux O., Arnaud L., et al. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis 65 (2006) 249-252
5. Kiely P.D., Bruckner F.E., Nisbet J.A., et al. Serum skeletal troponin I in inflammatory muscle disease: relation to creatine kinase, CKMB and cardiac troponin I. Ann Rheum Dis 59 (2000) 750-751
6. Erlacher P., Lercher A., Falkensammer J., et al. Cardiac troponin and beta-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis. Clin Chim Acta 306 (2001) 27-33
7. Targoff I.N. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am 28 (2002) 859-890
8. Hochberg M.C., Feldman D., and Stevens M.B. Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum 15 (1986) 168-178
9. Lambotte O., Kotb R., Maigne G., et al. Efficacy of rituximab in refractory polymyositis. J Rheumatol 32 (2005) 1369-1370
10. Barbasso Helmers S., Dastmalchi M., Alexanderson H., et al. Limited effects of high-dose intravenous immunoglobulin (IVIg) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies. Ann Rheum Dis 8 (2007) (ahead of print)
11. Efthimiou P., Schwartzman S., and Kagen L.J. Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients. Ann Rheum Dis 65 (2006) 1233-1236
12. Hengstman G.J., van den Hoogen F.H., Barrera P., et al. Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations. Eur Neurol 50 (2003) 10-15
13. Touma Z., Sayad J., and Arayssi T. Successful treatment of Sjogren's syndrome with rituximab. Scand J Rheumatol 35 (2006) 323-325
14. Levine T.D. Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 52 (2005) 601-607
15. Noss E.H., Hausner-Sypek D.L., and Weinblatt M.E. Rituximab as therapy for refractory polymyositis and dermatomyositis. J Rheumatol 33 (2006) 1021-1026
16. Chiappetta N., Steier J., and Gruber B. Rituximab in the treatment of refractory dermatomyositis. J Clin Rheumatol 11 (2005) 264-266
17. Itoh K., Kano T., Nagashio C., et al. Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus. Arthritis Rheum 54 (2006) 1020-1022